<DOC>
	<DOCNO>NCT00562783</DOCNO>
	<brief_summary>Cirrhosis diffuse lesion characterize architectural distortion liver collagen deposition development nodule regenerate hepatocytes . It irreversible change result diseases characterized chronic liver injury ( Fujimoto , 2000 ) . Cirrhosis alters pattern blood flow liver result impaired perfusion hepatic lobule intrahepatic extrahepatic shunting blood . This deprive hepatocytes uniform perfusion arterial portal venous blood result portal hypertension consequence cirrhosis include impaired protein synthesis alter drug metabolism . The histologic diagnosis cirrhosis require presence regenerative nodule pseudolobules completely encircle fibrosis congenital hepatic fibrosis result portal hypertension absence cirrhosis ( Anthony et al. , 1977 ) . The event lead development cirrhosis generally chronic injury hepatocyte destruction . Acute severe liver injury fulminant viral hepatitis result cirrhosis liver generally return normal recovery . Cirrhosis classify macroscopic appearance , cause , histologic appearance location liver damage . Micronodular cirrhosis compose uniform nodule less 3 mm diameter , whereas macronodular cirrhosis vary size nodule great 3 mm diameter . Mixed nodular cirrhosis nodule size . Some liver diseases alcoholic liver disease may present micronodular cirrhosis develop large nodule subsequent regeneration hepatocytes . For reason , many prefer etiologic classification ( e.g. , alcoholic cirrhosis ) . The designation cirrhosis post necrotic , biliary portal still commonly use imply predominant histologic location fibrosis . Cirrhosis irreversible disease , attempt make stabilize patient control cause . Factors indicate poor outcome include elevate prothrombin time correct parenteral vitamin K , upper gastrointestinal bleeding cause varix , ascites refractory therapy , increase age patient , sever malnutrition , spontaneous bacterial peritonitis , pronounced increase serum bilirubin absence haemolysis , heptocellular carcinoma ( Yeh et al. , 2003 ) . In general , cause upper GI bleeding associate increased mortality patient cirrhosis . For alcoholic cirrhosis lack portal hypertension , survival similar age-matched cohort alcohol intake stop ( Nakamura et al. , 1991 ) . If ethanol consumption continue , mortality high . Cirrhosis present without clinically significant complication identify autopsy evaluation abnormal liver test ( Mendez et al. , 2003 ) . However , many patient disease slowly progressive result one complication . The clinical manifestation cirrhosis result alter hepatic blood flow liver intrahepatic shunt causing impaired perfusion hepatocytes portal hypertension shunt blood around liver though portosystemic communication . The major complication portal hypertension include oesophageal gastric varix , ascites , portosystemic encephalopathy , hepatorenal-syndrome ( Menon &amp; Kamath , 2000 ) . With impairment hepatocyte perfusion reduction hepatocyte number , alter synthetic function result hypoalbuminemia , hypoprothrombinemia , change drug metabolism . Vitalliver Chinese medicine administer form suppository , uncommon Chinese medicine . Medications release suppository absorb directly circulation around rectum reach liver via portal vein . Basic pharmacological study show Vitalliver good immunomodulating function , increase activity T-cells , B-cells NK cell , therefore formulation may special value treat liver disease .</brief_summary>
	<brief_title>A Phase II , Double-blinded , Randomized , Controlled Study Evaluate Efficacy Safety Vitalliver Patients With Decompensated Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>HBV HCV relate liver cirrhosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>HBV</keyword>
	<keyword>HCV</keyword>
	<keyword>Liver cirrhosis</keyword>
</DOC>